Life Science Innovations Fund
Venture capitalBialystok · Seed–Series A · 1 people tracked
Investment thesis
Life Science Innovations Fund is a venture capital firm that invests in life sciences companies. The firm focuses on early-stage and growth-stage investments.
Team · 1 people
from the firm's websiteFrequently asked questions
- What stage does Life Science Innovations Fund invest at?
- Life Science Innovations Fund invests at the Seed, Series A stages.
- What sectors does Life Science Innovations Fund focus on?
- Life Science Innovations Fund focuses on Biotech, Cleantech, Healthtech, Medical Devices.
- Where is Life Science Innovations Fund located?
- Life Science Innovations Fund is headquartered in Bialystok, PL.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
Khosla Ventures is a technology-focused investment firm that seeks companies leveraging disruptive technological advances to solve large-scale problems across multiple industries. The firm emphasizes proprietary technology, business model innovation, and early-stage, bold investments with unfair advantages.